The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-Stakeholder Workshop

Digital Tools and Artificial Intelligence in Oncology Drug Development

27 – 28 September 2021, Online workshop

Presentations

SESSION 1: APPLYING AI IN CLINICAL DRUG DEVELOPMENT – KEY CHALLENGES

Keynote lecture – Dónal Landers (Digital Experimental Cancer Medicine Team, CRUK Manchester Institute, UK

SESSION 2: DIGITAL TOOLS IN CLINICAL TRIALS

Digital tools in trials for monitoring – Larsson Omberg (Sage Bionetworks, USA)

Endpoints using digital tools – Donna Graham (The Christie / Digital ECMT UK)

Digital tools for recruitment – Chris Plummer (Newcastle Hospitals NHS Foundation Trust, UK)

Regulatory aspects – Ib Alstrup (Danish Medicines Agency, DK)

SESSION 3: CLINICAL DECISION SUPPORT TOOLS AND CLINICAL PRACTICE

Regulatory considerations on EU trustworthy AI – Gabriele Mazzini (European Commission, IT)

Digital diagnosis – Joachim H. Schmid (Roche Tissue Diagnostic, USA)

How AI can support best diagnostic approaches in hematology – Torsten Haferlach (Munich Leukemia Laboratory, DE)

SESSION 4: DIGITAL TOOLS SUPPORTING INNOVATIVE PATIENT CARE

Patient perspective – Hans Scheurer (WECAN, MPE , NL)

Clinician perspective – Sanna Iivanainen (Oulu University Hospital, FI)

Regulatory aspects – Bleddyn Rees (European Connected Health Alliance, IE)

ESSION 5: INTEGRATION OF PATIENTS IN DIGITAL TOOL TRIAL DESIGN AND DEVELOPMENT

Patient engagement in designing the clinical studies – Leanna Goodwin (Digital Experimental Cancer Medicine Team, CRUK Manchester Institute, UK)

Design and delivery of the In-home study – Leanne Philips (Manchester Foundation Trust / Digital ECMT, UK)

Data security and regulation – Petra Wilson (Health Connect Partners, BE)